Stem Cell Research (Sep 2023)
Modelling Duchenne muscular dystrophy in vitro with newly generated, blood cell-derived induced pluripotent stem cell line ORIONi003-A
- Dominika Hajduchova,
- Stanislava Suroviakova,
- Sandra Mersakova,
- Dusan Brany,
- Romana Zahumenska,
- Martin Rehak,
- Henrieta Skovierova,
- Slavomíra Nováková,
- Vladimir Nosal,
- Juraj Marcinek,
- Michal Kalman,
- Martin Jozef Pec,
- Mariana Brozmanova,
- Jana Melegova,
- Stefan Juhas,
- Jana Juhasova,
- Hana Studenovska,
- Barbora Mitruskova,
- Michal Pokusa,
- Marek Samec,
- Matej Samos,
- Andreas Nicodemou,
- Lubos Danisovic,
- Zuzana Dankova,
- Egon Kurca,
- Katarina Lexova Kolejakova,
- Jan Chandoga,
- Lukas Plank,
- Erika Halasova,
- Renata Pecova,
- Jan Strnadel
Affiliations
- Dominika Hajduchova
- Department of Pathological Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Stanislava Suroviakova
- Department of Pediatric Neurology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, and University Hospital Martin, Slovakia
- Sandra Mersakova
- Biomedical Centre Martin JFM CU, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Dusan Brany
- Biomedical Centre Martin JFM CU, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Romana Zahumenska
- Biomedical Centre Martin JFM CU, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Martin Rehak
- Biomedical Centre Martin JFM CU, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Henrieta Skovierova
- Biomedical Centre Martin JFM CU, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Slavomíra Nováková
- Biomedical Centre Martin JFM CU, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Vladimir Nosal
- Clinic of Neurology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, and University Hospital Martin, Martin, Slovakia
- Juraj Marcinek
- Department of Pathological Anatomy, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, and University Hospital Martin, Slovakia
- Michal Kalman
- Department of Pathological Anatomy, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, and University Hospital Martin, Slovakia
- Martin Jozef Pec
- Department of Internal Medicine I, University Hospital Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Mariana Brozmanova
- Department of Pathological Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia; Central Animal Facility, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Jana Melegova
- Central Animal Facility, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Stefan Juhas
- Institute of Animal Physiology and Genetics, Czech Academy of Sciences, v.v.i, Liběchov, Czech Republic
- Jana Juhasova
- Institute of Animal Physiology and Genetics, Czech Academy of Sciences, v.v.i, Liběchov, Czech Republic
- Hana Studenovska
- Department of Biomaterials and Bioanalogous Systems Institute of Macromolecular Chemistry Czech Academy of Sciences, Prague, Czech Republic
- Barbora Mitruskova
- Department of Clinical Genetics, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, and University Hospital, Martin, Slovakia
- Michal Pokusa
- Biomedical Centre Martin JFM CU, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Marek Samec
- Department of Pathological Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Matej Samos
- Department of Internal Medicine I, University Hospital Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Andreas Nicodemou
- Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, Slovakia
- Lubos Danisovic
- Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, Slovakia
- Zuzana Dankova
- Biomedical Centre Martin JFM CU, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Egon Kurca
- Clinic of Neurology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, and University Hospital Martin, Martin, Slovakia
- Katarina Lexova Kolejakova
- Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, Slovakia
- Jan Chandoga
- Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, Slovakia
- Lukas Plank
- Department of Pathological Anatomy, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, and University Hospital Martin, Slovakia
- Erika Halasova
- Biomedical Centre Martin JFM CU, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Renata Pecova
- Department of Pathological Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
- Jan Strnadel
- Biomedical Centre Martin JFM CU, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia; Corresponding author.
- Journal volume & issue
-
Vol. 71
p. 103187
Abstract
Here, we present newly derived in vitro model for modeling Duchenne muscular dystrophy. Our new cell line was derived by reprogramming of peripheral blood mononuclear cells (isolated from blood from pediatric patient) with Sendai virus encoding Yamanaka factors. Derived iPS cells are capable to differentiate in vitro into three germ layers as verified by immunocytochemistry. When differentiated in special medium, our iPSc formed spontaneously beating cardiomyocytes. As cardiomyopathy is the main clinical complication in patients with Duchenne muscular dystrophy, the cell line bearing the dystrophin gene mutation might be of interest to the research community.
